Usefulness of Septodermoplasty in Hereditary Hemorrhagic Telangiectasia.
10.3342/kjorl-hns.2015.58.5.330
- Author:
Chan Joo YANG
1
;
Bong Jae LEE
;
Yong Ju JANG
Author Information
1. Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jangyj@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Epistaxis;
Hereditary hemorrhagic telangiectasia
- MeSH:
Epistaxis;
Hemorrhage;
Humans;
Retrospective Studies;
Telangiectasia, Hereditary Hemorrhagic*
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2015;58(5):330-336
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: Epistaxis is the most common symptom in patients with hereditary hemorrhagic telangiectasia (HHT). The aim of this study is to report treatment of severe epistaxis related to HHT with the septodermoplasty and to assess patient outcomes. SUBJECTS AND METHOD: Six patients with HHT who underwent septodermoplasty from 2009 to 2013 were reviewed retrospectively. We analyzed the clinical characteristics, surgical management and treatment outcomes. RESULTS: Three patients had been diagnosed with definite HHT and three patients with possible HHT. Three patients had combined abnormal vascular structures in visceral organs. The mean preoperative and postoperative hemoglobin were 7.2 g/dL and 12.8 g/dL, respectively, and visual analogue scale score for frequency and intensity of nasal bleeding remarkably decreased after septodermoplasty in all patients. CONCLUSION: Septodermoplasty was a safe and efficacious procedure for reducing the frequency and severity of bleeding in most patients with intractable epistaxis and HHT.
